lenvatinib,Atezolizumab,Bevacizumab,Sorafenib
eisai,Bayer,Roche
[]
lenvatinib following progression on immunotherapy demonstrates efficacy in second-line hcc via #gi23
Co-founder @MassiveBio | Director of Oncology Research @capitalhealthnj | Entrepreneur | #genomics #Tech #AI #trials #cancer #GPT #unicorn #A17a -My Opinion